Leptin in supraphysiological doses in vitro is known to block insulin interaction with its receptor on the cell membrane, which is associated with impaired insulin-mediated glucose transport, hyperglycaemia and more severe IR [15,16]. This evidence concerns the gene LEP and Hyperglycemia.